The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival (OS) with CPX-351 versus 7+3 in older adults with newly diagnosed, therapy-related acute myeloid leukemia (tAML): Subgroup analysis of a phase III study.
 
Jeffrey E. Lancet
Consulting or Advisory Role - Asterias Biotherapeutics; Baxalta; Bio-Path Holdings, Inc; Biosight; Boehringer Ingelheim; Celator; Celgene; ERYTECH Pharma; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Novartis
Research Funding - Pfizer (Inst)
 
David Rizzieri
Consulting or Advisory Role - Abbvie; Novartis; Pfizer; Spectrum Pharmaceuticals; Teva
Speakers' Bureau - Celgene; Gilead Sciences; Incyte; Millennium (I); Seagen
 
Gary J. Schiller
Research Funding - Celator
 
Robert K. Stuart
Honoraria - Sunesis Pharmaceuticals
Consulting or Advisory Role - Sunesis Pharmaceuticals
Research Funding - Agios; Astellas Pharma; Bayer; Celator; Incyte; Sunesis Pharmaceuticals
Travel, Accommodations, Expenses - Sunesis Pharmaceuticals
 
Jonathan E. Kolitz
Stock and Other Ownership Interests - Celgene
Honoraria - Gilead Sciences; Magellan Health; Novartis
Consulting or Advisory Role - Gilead Sciences; Magellan Health; Novartis; Pharmacyclics; Seagen
Research Funding - Boehringer Ingelheim; Cantex Pharmaceuticals; ERYTECH Pharma; Millennium
Travel, Accommodations, Expenses - Gilead Sciences; Novartis; Seagen
 
Scott R. Solomon
No Relationships to Disclose
 
Laura F. Newell
No Relationships to Disclose
 
Harry Paul Erba
Consulting or Advisory Role - Amgen; Celator; Celgene; Daiichi Sankyo; ImmunoGen; Incyte; Millennium; Novartis; Ono Pharmaceutical; Pfizer; Seagen; Sunesis Pharmaceuticals
Speakers' Bureau - Celgene; Incyte; Novartis
Research Funding - Agios; Amgen; Astellas Pharma; Celator; Daiichi Sankyo; ImmunoGen; Janssen; Juno Therapeutics; Millennium; Seagen
Other Relationship - Celgene; GlycoMimetics
 
Geoffrey L. Uy
Consulting or Advisory Role - Boehringer Ingelheim; Glycomimetics; Novartis
Travel, Accommodations, Expenses - Novartis
 
Robert Ryan
Employment - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Jazz Pharmaceuticals
 
Michael Chiarella
Employment - Celator; Jazz Pharmaceuticals
Stock and Other Ownership Interests - Celator; Jazz Pharmaceuticals
 
Arthur Chin Louie
Employment - Jazz Pharmaceuticals
Leadership - Jazz Pharmaceuticals
Stock and Other Ownership Interests - Celator; Jazz Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Celator
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; ARIAD; BiolineRx; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Teva (Inst)